Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Sep;64(9):1015-1027.
doi: 10.1111/myc.13328. Epub 2021 Jun 14.

Mortality in critically ill patients with coronavirus disease 2019-associated pulmonary aspergillosis: A systematic review and meta-analysis

Shreya Singh  1 , Nipun Verma  2 , Rimjhim Kanaujia  1 , Arunaloke Chakrabarti  1 , Shivaprakash M Rudramurthy  1
Affiliations
Meta-Analysis

Mortality in critically ill patients with coronavirus disease 2019-associated pulmonary aspergillosis: A systematic review and meta-analysis

Shreya Singh et al. Mycoses. 2021 Sep.

Abstract

Reports of COVID-19 associated pulmonary aspergillosis (CAPA) are rising, but the associated mortality and factors affecting it are not well-characterised. We performed a systematic review including 20 peer-reviewed English language studies reporting mortality in CAPA published till 18 February 2021from PubMed, Ovid SP, Web of Science, Embase and CINHAL. The pooled mortality in CAPA was 51.2% (95% CI: 43.1-61.1, I2 = 38%). The leave one out sensitivity analysis and influential case diagnostics revealed one outlier and its exclusion resulted in a mortality estimate of 54% (95% CI: 45-62). Higher odds of mortality: 2.83 (95% CI: 1.8-4.5) were seen in CAPA compared to controls. No significant difference in various subgroups according to the country of study, the continent of study, income category of country and quality of the included study was seen. None of the host risk factors, mycological test results, therapy for COVID-19 and antifungal therapy affected mortality. Thus, patients with CAPA have a high probability of mortality and early diagnosis with prompt therapy must be ensured to optimally manage these patients. However, more prospective studies with global and multi-centre coordination may help to address CAPA in a better way.

Keywords: COVID-19; meta-analysis; mortality; pulmonary aspergillosis; systematic review.

PubMed Disclaimer

References

REFERENCES

    1. Dhama K, Khan S, Tiwari R, et al. Coronavirus disease 2019-COVID-19. Clin Microbiol Rev. 2020;33:1-48. https://doi.org/10.1128/CMR.00028-20
    1. Vakili K, Fathi M, Pezeshgi A, et al. Reviews in Cardiovascular Medicine. 2020;21:433-442. https://doi.org/10.31083/j.rcm.2020.03.12
    1. Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81:266-275. https://doi.org/10.1016/j.jinf.2020.05.046
    1. Tavakolpour S, Rakhshandehroo T, Wei EX, Rashidian M. Lymphopenia during the COVID-19 infection: what it shows and what can be learned. Immunol Lett. 2020;225:31-32. https://doi.org/10.1016/j.imlet.2020.06.013
    1. Fara A, Mitrev Z, Rosalia RA, Assas BM. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines: cytokine storm: the elements of rage!. Open Biol. 2020;10:200160. https://doi.org/10.1098/rsob.200160

MeSH terms

Substances

LinkOut - more resources